Additional research has confirmed the cardioprotective effects of SPRC in animal models of heart failure [86], myocardial infarction [87], doxorubicin-induced cardiotoxicity [88], hypoxic stress [89], and glucose-mediated damage [90]. This evidence concerns the gene SPRR3 and heart failure.